Home > Healthcare > Pharmaceuticals > Finished Drug Form > Growth Hormone Market
Growth Hormone Market Share
- Report ID: GMI5042
- Published Date: Jul 2023
- Report Format: PDF
Growth Hormone Market Share
- Novo Nordisk A/S
- Novartis AG
- Merck KGaA
- Anhui Anke Biotechnology (Group) Co., Ltd
- Pfizer Inc
- Eli Lily And Company
- Ipsen S.A.
Frequently Asked Questions (FAQ) :
Growth hormone industry was valued at over USD 3.3 billion in 2022 and will grow at more than 6% CAGR from 2023 to 2032, attributed to the rising prevalence of growth hormone deficiency globally.
The growth hormone powder segment size will reach over USD 3.9 billion by 2032, owing to its ease of storage, cost-effectiveness, and long shelf life.
North America growth hormone market amassed over 43% revenue share in 2022 on account of huge investment in R&D activities for the development of innovative growth hormone medications in the region.
Major growth hormone industry players include Novo Nordisk A/S, Novartis AG, Merck KGaA, Ipsen S.A., Pfizer Inc., Eli Lily And Company, and Anhui Anke Biotechnology (Group) Co., Ltd, among others.
Growth Hormone Market Scope
×
Get a free sample of
Growth Hormone Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below